Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (CHARGE-FHS) C UKPDSBB PO 60 (42%) 3889 (55%) 76 (11) - - - 64 (12) - 9,223

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs139447 chr22:41609430 L3MBTL2 A vs. G All: C 15 108,990 0.292 (A) 0.167 (A) 1.07 (1.03-1.10) 11 (0-48) 8.67e-05
rs139448 chr22:41609443 L3MBTL2 T vs. C All: C 15 108,990 0.292 (T) 0.167 (T) 1.07 (1.03-1.10) 11 (0-49) 8.77e-05
rs139451 chr22:41610024 L3MBTL2 A vs. G All: C 15 108,990 0.292 (A) 0.15 (A) 1.07 (1.03-1.10) 11 (0-49) 9.82e-05
rs139456 chr22:41610449 L3MBTL2 G vs. A All: C 14 106,157 0.292 (G) 0.15 (G) 1.07 (1.04-1.11) 14 (0-52) 6.87e-05
rs139457 chr22:41610667 L3MBTL2 C vs. T All: C 15 108,990 0.3 (C) 0.117 (C) 1.08 (1.04-1.12) 18 (0-55) 5.43e-05
rs139458 chr22:41610668 L3MBTL2 A vs. G All: C 15 108,990 0.3 (A) 0.117 (A) 1.08 (1.04-1.12) 18 (0-55) 5.43e-05
rs62238732 chr22:41611708 L3MBTL2 A vs. G All: C 15 108,990 - - 0.92 (0.89-0.96) 19 (0-55) 6.68e-05
rs85220 chr22:41612965 L3MBTL2 G vs. T All: C 15 108,990 0.283 (G) 0.15 (G) 1.07 (1.03-1.10) 8 (0-45) 8.17e-05
rs139470 chr22:41616516 L3MBTL2 C vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 12 (0-50) 8.72e-05
rs139475 chr22:41623996 L3MBTL2 T vs. C All: C 15 108,990 0.292 (T) 0.167 (T) 1.07 (1.04-1.11) 7 (0-43) 5.70e-05
rs139478 chr22:41624761 L3MBTL2 G vs. A All: C 15 108,990 - - 0.94 (0.91-0.97) 8 (0-45) 5.21e-05
rs3721 chr22:41627073 L3MBTL2 T vs. C All: C 15 108,990 0.292 (T) 0.167 (T) 1.07 (1.03-1.10) 11 (0-48) 6.47e-05
rs139484 chr22:41627543 CHADL G vs. T All: C 15 108,990 0.292 (G) 0.167 (G) 1.07 (1.03-1.10) 11 (0-48) 6.11e-05
rs139485 chr22:41627606 CHADL A vs. G All: C 15 108,990 0.292 (A) 0.158 (A) 1.07 (1.03-1.10) 8 (0-44) 6.57e-05
rs139492 chr22:41628902 CHADL T vs. G All: C 15 108,990 0.283 (T) 0.108 (T) 1.07 (1.03-1.10) 0 (0-52) 9.04e-05
rs139493 chr22:41632079 CHADL C vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 2 (0-55) 1.06e-04
rs5767275 chr22:46981234 GRAMD4 C vs. T All: C 15 108,990 - - 1.09 (1.05-1.12) 0 (0-25) 1.44e-06
rs5767281 chr22:46986889 GRAMD4 A vs. G All: C 15 108,990 0.367 (A) 0.125 (G) 0.92 (0.89-0.95) 0 (0-27) 5.21e-07
rs8142773 chr22:46993449 GRAMD4 T vs. C All: C 15 108,990 - - 1.07 (1.04-1.11) 0 (0-47) 2.58e-05
rs10220344 chrY:19917246 RNU1-128P [+16204bp] T vs. C All: C 15 108,990 - - 1.15 (1.10-1.20) 34 (0-64) 2.39e-10
rs11626155 chrY:19917330 RNU1-128P [+16288bp] C vs. T All: C 15 108,990 - - 1.11 (1.06-1.16) 34 (0-65) 2.32e-06
rs62184162 chrY:23228806 intergenic T vs. C All: C 15 108,990 - - 1.09 (1.04-1.13) 0 (0-42) 6.18e-05
rs190266 chr17:44019063 MAPT T vs. G All: C 13 97,715 - - 0.82 (0.78-0.86) 26 (0-62) 7.64e-16